Fresolimumab and Radiotherapy in Metastatic Breast Cancer.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 19 Mar 2018
At a glance
- Drugs Fresolimumab (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 14 Mar 2018 Planned End Date changed from 1 Jun 2017 to 1 Jun 2019.
- 23 Feb 2018 Results published in the Clinical cancer research: an official journal of the American Association for Cancer Research
- 21 Feb 2017 Planned End Date changed from 1 Mar 2016 to 1 Jun 2017.